Their findings indicate that MEF2C protein levels were unchanged, but MEF2C immunoreactivity was more frequently observed outside the nuclei in sporadic ALS PBMCs, while in healthy control, the signal was more diffused within the nucleus. Here, MEF2C is linked to amyotrophic lateral sclerosis.